Search

Your search keyword '"Hoschler, Katja"' showing total 238 results

Search Constraints

Start Over You searched for: Author "Hoschler, Katja" Remove constraint Author: "Hoschler, Katja" Language english Remove constraint Language: english
238 results on '"Hoschler, Katja"'

Search Results

2. Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

3. Genomic investigations of unexplained acute hepatitis in children

4. Paediatric acute hepatitis of unknown aetiology: a national investigation and adenoviraemia case-control study in the UK

6. Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study

7. Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England

10. Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK

11. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

16. End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain.

17. Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.

19. Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

20. Optimizing Mood Prior to Influenza Vaccination in Older Adults: A Three-Arm Randomized Controlled Trial.

21. A case of swine influenza A(H1N2)v in England, November 2023.

23. Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study

27. High attack rate in a large care home outbreak of SARS-CoV-2 BA.2.86, East of England, August 2023.

30. H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study

32. Fast Rise of Broadly Cross-Reactive Antibodies after Boosting Long-Lived Human Memory B Cells Primed by an MF59 Adjuvanted Prepandemic Vaccine

33. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines

37. Humoral and Cellular Immunity to Primary H1N1 Infection in Patients with Hematologic Malignancies following Stem Cell Transplantation

39. An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.

40. Incidence of influenza A(H1N1) pdm09 infection, United Kingdom, 2009-2011

41. Cellular immune correlates of protection against symptomatic pandemic influenza

42. Seroprevalence of influenza A(H1N1) pdm09 virus antibody, England, 2010 and 2011

43. Seroepidemiologic study of pandemic (H1N1) 2009 during outbreak in boarding school, England

45. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom

46. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine

47. Reproducibility of serologic assays for influenza virus A (H5N1)

Catalog

Books, media, physical & digital resources